Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sex, erectile dysfunction, and the heart: a growing problem].

Günter Görge1, Stephan Flüchter, Michael Kirstein

  • 1Klinik für Herz- und Lungenkrankheiten, Angiologie und Intensivmedizin, Klinikum Saarbrücken, Germany. ggoerge@klinikum-saarbruecken.de

Herz
|June 26, 2003
PubMed
Summary

Erectile dysfunction (ED) shares risk factors with cardiovascular disease. Patients with ED require cardiovascular evaluation before using phosphodiesterase-5 inhibitors like sildenafil due to potential cardiac risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of volatile metabolites formed by molds on barley by mass and ion mobility spectrometry.

Journal of mass spectrometry : JMS·2020
Same author

[Digital public health: data protection and data security].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2020
Same author

Effect of Malt-Derived Potential Antioxidants on Dimethyl Sulfide Oxidation.

Journal of agricultural and food chemistry·2018
Same author

Relevance of Oxygen for the Formation of Strecker Aldehydes during Beer Production and Storage.

Journal of agricultural and food chemistry·2016
Same author

[Not Available].

Zeitschrift fur Kardiologie·2014
Same author

Labeling of single cells in the central nervous system of Drosophila melanogaster.

Journal of visualized experiments : JoVE·2013

Area of Science:

  • Cardiology
  • Urology
  • Pharmacology

Context:

  • Erectile dysfunction (ED) shares common risk factors with cardiovascular disease (CVD), including hypertension, diabetes, and smoking.
  • ED can be an early indicator of underlying CVD, necessitating thorough patient assessment.
  • Sexual activity itself exerts a cardiac and metabolic demand, with risks potentially amplified in individuals with pre-existing CVD.

Purpose:

  • To review the cardiovascular implications of sexual activity and the use of phosphodiesterase-5 (PDE5) inhibitors for ED treatment.
  • To highlight the safety profile of sildenafil, particularly in patients with CVD.
  • To provide guidance on risk stratification and management for patients with ED and cardiovascular concerns.

Summary:

  • Sexual activity requires a metabolic expenditure comparable to light to moderate exercise.

Related Experiment Videos

  • Sildenafil, a PDE5 inhibitor, is generally safe for healthy individuals but carries risks for patients with CVD, especially when combined with nitrates.
  • Contraindications for sildenafil include nitrate use, severe aortic stenosis, and hypertrophic obstructive cardiomyopathy; cardiovascular evaluation is crucial.

    • Impact:

    • Emphasizes the critical need for cardiovascular assessment in all ED patients prior to initiating PDE5 inhibitor therapy.
    • Informs clinical decision-making regarding the safe use of sildenafil in patients with varying cardiovascular profiles.
    • Promotes a comprehensive approach to managing ED, integrating urological and cardiological care to optimize patient outcomes and safety.